InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,982.40
(
-1.17%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.22
(
-0.06%
)
Bitcoin
61,342.69
(
1.80%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 143

Monday, 05/07/2018 12:48:13 AM

Monday, May 07, 2018 12:48:13 AM

Post# of 438
ARWR recently refined its pipeline by clarifying that its preclinical Aro-Lung1 program is a cystic Fibrosis treatment.

Partnered program with AMGN may gnerate a progress milestone payment in 2018.

raised cash EOY/17 to bring cash to ~$100mn. At present burn rate, this would last midway into 2019.

There's really not much to see here at this point.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up